Skip to main content

Moberg Pharma Annual Report 2015

Moberg Pharma´s Annual Report for 2015 has been published and is available on

About this information               
Moberg Pharma discloses this information pursuant to the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 8.30 a.m. (CET) on April 19, 2016.

For additional information contact:
Peter Wolpert, CEO; Phone: +46 (0)70 - 735 71 35; E-mail:  
Anna Ljung, CFO, Phone: +46 (0)70- 766 60 30; Email: